215 related articles for article (PubMed ID: 27203743)
1. The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.
Le Clorennec C; Lazrek Y; Dubreuil O; Larbouret C; Poul MA; Mondon P; Melino G; Pèlegrin A; Chardès T
Oncotarget; 2016 Jun; 7(24):37013-37029. PubMed ID: 27203743
[TBL] [Abstract][Full Text] [Related]
2. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
3. Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3.
Le Clorennec C; Bazin H; Dubreuil O; Larbouret C; Ogier C; Lazrek Y; Garambois V; Poul MA; Mondon P; Barret JM; Mathis G; Prost JF; Pèlegrin A; Chardès T
Mol Cancer Ther; 2017 Jul; 16(7):1312-1323. PubMed ID: 28507002
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
[TBL] [Abstract][Full Text] [Related]
5. Impact of JNK1, JNK2, and ligase Itch on reactive oxygen species formation and survival of prostate cancer cells treated with diallyl trisulfide.
Sielicka-Dudzin A; Borkowska A; Herman-Antosiewicz A; Wozniak M; Jozwik A; Fedeli D; Antosiewicz J
Eur J Nutr; 2012 Aug; 51(5):573-81. PubMed ID: 21863240
[TBL] [Abstract][Full Text] [Related]
6. Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.
Lazrek Y; Dubreuil O; Garambois V; Gaborit N; Larbouret C; Le Clorennec C; Thomas G; Leconet W; Jarlier M; Pugnière M; Vié N; Robert B; Monnet C; Bouayadi K; Kharrat H; Mondon P; Pèlegrin A; Chardès T
Neoplasia; 2013 Mar; 15(3):335-47. PubMed ID: 23479511
[TBL] [Abstract][Full Text] [Related]
7. Functional genomic characterization of a synthetic anti-HER3 antibody reveals a role for ubiquitination by RNF41 in the anti-proliferative response.
Turowec JP; Lau EWT; Wang X; Brown KR; Fellouse FA; Jawanda KK; Pan J; Moffat J; Sidhu SS
J Biol Chem; 2019 Jan; 294(4):1396-1409. PubMed ID: 30523157
[TBL] [Abstract][Full Text] [Related]
8. The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation.
Omerovic J; Santangelo L; Puggioni EM; Marrocco J; Dall'Armi C; Palumbo C; Belleudi F; Di Marcotullio L; Frati L; Torrisi MR; Cesareni G; Gulino A; Alimandi M
FASEB J; 2007 Sep; 21(11):2849-62. PubMed ID: 17463226
[TBL] [Abstract][Full Text] [Related]
9. HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.
Thomas G; Chardès T; Gaborit N; Mollevi C; Leconet W; Robert B; Radosevic-Robin N; Penault-Llorca F; Gongora C; Colombo PE; Lazrek Y; Bras-Goncalves R; Savina A; Azria D; Bazin H; Pèlegrin A; Larbouret C
Oncotarget; 2014 Aug; 5(16):7138-48. PubMed ID: 25216528
[TBL] [Abstract][Full Text] [Related]
10. Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets.
Hooper C; Puttamadappa SS; Loring Z; Shekhtman A; Bakowska JC
BMC Biol; 2010 May; 8():72. PubMed ID: 20504295
[TBL] [Abstract][Full Text] [Related]
11. An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
Bourillon L; Bourgier C; Gaborit N; Garambois V; Llès E; Zampieri A; Ogier C; Jarlier M; Radosevic-Robin N; Orsetti B; Delpech H; Theillet C; Colombo PE; Azria D; Pèlegrin A; Larbouret C; Chardès T
Int J Cancer; 2019 Oct; 145(7):1838-1851. PubMed ID: 30882895
[TBL] [Abstract][Full Text] [Related]
12. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4.
Bhandari D; Trejo J; Benovic JL; Marchese A
J Biol Chem; 2007 Dec; 282(51):36971-9. PubMed ID: 17947233
[TBL] [Abstract][Full Text] [Related]
13. A model of partnership co-opted by the homeodomain protein TGIF and the Itch/AIP4 ubiquitin ligase for effective execution of TNF-alpha cytotoxicity.
Demange C; Ferrand N; Prunier C; Bourgeade MF; Atfi A
Mol Cell; 2009 Dec; 36(6):1073-85. PubMed ID: 20064471
[TBL] [Abstract][Full Text] [Related]
14. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Parsa AT; Pieper RO
Cancer Res; 2009 Oct; 69(20):7911-6. PubMed ID: 19808964
[TBL] [Abstract][Full Text] [Related]
15. AIP4/Itch regulates Notch receptor degradation in the absence of ligand.
Chastagner P; Israël A; Brou C
PLoS One; 2008 Jul; 3(7):e2735. PubMed ID: 18628966
[TBL] [Abstract][Full Text] [Related]
16. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.
Vartanian R; Masri J; Martin J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Gera J
Mol Cancer Res; 2011 Jan; 9(1):115-30. PubMed ID: 21135252
[TBL] [Abstract][Full Text] [Related]
17. Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.
Malik R; Soh UJ; Trejo J; Marchese A
J Biol Chem; 2012 Mar; 287(12):9013-27. PubMed ID: 22275353
[TBL] [Abstract][Full Text] [Related]
18. The E3 ubiquitin ligase NEDD4 negatively regulates HER3/ErbB3 level and signaling.
Huang Z; Choi BK; Mujoo K; Fan X; Fa M; Mukherjee S; Owiti N; Zhang N; An Z
Oncogene; 2015 Feb; 34(9):1105-15. PubMed ID: 24662824
[TBL] [Abstract][Full Text] [Related]
19. Pirh2, an E3 ligase, regulates the AIP4-p73 regulatory pathway by modulating AIP4 expression and ubiquitination.
Abou Zeinab R; Wu HH; Abuetabh Y; Leng S; Sergi C; Eisenstat DD; Leng RP
Carcinogenesis; 2021 Apr; 42(4):650-662. PubMed ID: 33569599
[TBL] [Abstract][Full Text] [Related]
20. Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH.
Courbard JR; Fiore F; Adélaïde J; Borg JP; Birnbaum D; Ollendorff V
J Biol Chem; 2002 Nov; 277(47):45267-75. PubMed ID: 12226085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
